AdCella and Shanghai Cell Therapy Group launch global collaboration on groundbreaking cancer therapy

Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...

January 15, 2026 | Thursday | News
Taiwan's Leadgene Biosolutions expands product portfolio for metabolic research

Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...

January 14, 2026 | Wednesday | News
Rakuten Medical and Lotte Biologics ink agreement to support biopharma in global oncology programme

US-based Rakuten Medical, Inc. and South Korea's Lotte Biologics have signed a biopharmaceutical contract manufacturing ...

January 14, 2026 | Wednesday | News
China's WuXi Biologics unveils new platform to transform bioprocessing and manufacturing

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

January 13, 2026 | Tuesday | News
Curi Bio launches Asia-Pacific hub following full acquisition of Quvit Bio in South Korea

US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...

January 13, 2026 | Tuesday | News
Novartis to build 4th radioligand therapy facility in US, expanding $23 B investment

Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy ...

January 13, 2026 | Tuesday | News
Nuvation Bio and Eisai license Taletrectinib rights outside US, China and Japan for $230 M

US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer trea...

January 13, 2026 | Tuesday | News
Taiwan's OBI Pharma inks agreement US-based TegMine Therapeutics for glycan-targeting ADC

Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...

January 13, 2026 | Tuesday | News
Japan's Takeda partners with Halozyme to continue advancing Vedolizumab with ENHANZE® drug-delivery technology

Japanese pharmaceutical firm Takeda has announced a global collaboration and license agreement with US-based Halozyme Th...

January 12, 2026 | Monday | News
China's MediLink signs additional exclusive licensing deal with Roche for $570 M

China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...

January 12, 2026 | Monday | News
Revvity collaborates with Eli Lilly to expand access to AI drug discovery models

US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...

January 12, 2026 | Monday | News
SK bioscience and Sanofi launch MenQuadfi meningococcal vaccine in Korea

SK bioscience has announced the new domestic launch of MenQuadfi Injection (MenQuadfi, MenACWY-TT), a quadrivalent menin...

January 12, 2026 | Monday | News
Santhera licenses AGAMREE to Japan's Nxera Pharma in $205 M Asia-Pacific deal

Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...

January 9, 2026 | Friday | News
Taiwan’s Foresee Pharma inks $584.5M deal with Primevera Therapeutics

Taiwan-based Foresee Pharmaceuticals has announced that Foresee Pharmaceuticals USA Inc., the company's fully-owned US s...

January 9, 2026 | Friday | News
Korea's Sky Labs secures European approval for ring-type blood pressure monitor

South Korea based startup Sky Labs has announced that its ring-type blood pressure monitor, 'CART PLATFORM,' recent...

January 9, 2026 | Friday | News
Ribo Life Science successfully lists on Main Board of Hong Kong Stock Exchange

Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...

January 9, 2026 | Friday | News
Kyorin and Lunatus partner to launch Lasvic tablets in nine Middle Eastern countries

Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulti...

January 8, 2026 | Thursday | News
Xellar, Woojung Bio to advance AI-enabled organ-on-a-chip preclinical models

US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...

January 8, 2026 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls